Janssen Pharmaceutica (Resolor Development And Marketing Rights) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Janssen Pharmaceutica (Resolor Development And Marketing Rights) General Information

Description

A portfolio of development and marketing right for prucalopride. The asset is mainly used for treatment of chronic constipation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Acquirer
Primary Office
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen Pharmaceutica (Resolor Development And Marketing Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Janssen Pharmaceutica (Resolor Development And Marketing Rights)‘s full profile, request access.

Request a free trial

Janssen Pharmaceutica (Resolor Development And Marketing Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Janssen Pharmaceutica (Resolor Development And Marketing Rights)‘s full profile, request access.

Request a free trial